Effect of omega-3 fatty acid supplementation on serum nitric oxide levels
Phase 2
- Conditions
- Atherosclerotic Heart Disease.Atherosclerotic heart disease
- Registration Number
- IRCT2017081335665N1
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 42
Inclusion Criteria
Cardiac patients, Lack of other diseases,Avoid dietary supplements, vitamins at least 4-6 weeks before and throughout the intervention, No diet, supplements or special activity. Exclusion criteria: A reaction to Omega compounds
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of mean serum NO level before and after intervention in the omega-3 fatty acid supplement group compared to placebo group. Timepoint: 2Month. Method of measurement: Elisa.
- Secondary Outcome Measures
Name Time Method Body Mass Index (BMI). Timepoint: Before and after 2 months of intervention. Method of measurement: Weight ratio to squared height.;Weight. Timepoint: Before and after 2 months of intervention. Method of measurement: seca scale in kilograms.;Waist. Timepoint: Before and after 2 months of intervention. Method of measurement: Band meters in cm.